Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ortho firms mark end of deferred prosecution agreements

This article was originally published in The Gray Sheet

Executive Summary

All five top orthopedic implant makers emerge from an 18-month period of federal monitoring of compliance policies related to surgeon consulting agreements with no new restrictions attached, the Department of Justice announces March 30. Deferred prosecution agreements entered into by four of the firms - Johnson & Johnson/DePuy, Zimmer, Biomet and Smith & Nephew - in September 2007 have now expired and related anti-kickback charges have been dismissed "as a result of the companies' successful completion" of the program, DoJ says. The firms remain subject to corporate integrity agreements with HHS through September 2012. The fifth manufacturer - Stryker - which was subject to the same reform requirements as its competitors as well as monitoring, also has satisfactorily met the terms of a non-prosecution agreement, Justice notes. The government had accused the firms of using surgeon consulting agreements as inducements for product selection (1"The Gray Sheet" Oct. 1, 2007, p. 3)
Advertisement

Related Content

Ortho Industry Reaches $311 Mil. Settlement With DoJ On Kickback Charges
Ortho Industry Reaches $311 Mil. Settlement With DoJ On Kickback Charges

Topics

Advertisement
UsernamePublicRestriction

Register

MT027298

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel